0.00

100.00% -0.048

Io Biotech Inc (IOBT)

概要ニュース株価時系列 Financials ディスカッション予測

前日終値:

$0.048

開ける：

24時間の取引高:

Relative Volume:

0.00

時価総額：

$3.45M

収益：

当期純損益:

$-88.35M

株価収益率:

0.00

EPS:

-1.3391

ネットキャッシュフロー:

$-81.07M

1週間パフォーマンス:

-100.00%

1か月パフォーマンス:

-100.00%

6か月パフォーマンス:

-100.00%

1年パフォーマンス:

-100.00%

1日の値動き範囲:

$0.00

1週間の範囲:

$0.00

52週間の値動き範囲:

$0.00

$2.79

Io Biotech Inc Stock (IOBT) Company Profile

名前

Io Biotech Inc

セクター

Healthcare (1109)

産業

Biotechnology (621)

電話

(457) 070-2980

住所

OLE MAALOES VEH 3, COPENHAGEN

職員

Twitter

次回の収益日

2026-05-13

最新のSEC提出書

IOBT's Discussions on Twitter

Compare IOBT vs VRTX, REGN, ARGX, ALNY, RVMD

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
IOBT Io Biotech Inc	0.00	3.45M	0	-88.35M	-81.07M	-1.3391
VRTX Vertex Pharmaceuticals Inc	444.93	112.92B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	612.14	64.18B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	893.52	55.57B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	282.85	37.76B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	153.87	32.71B	742.00K	-1.37B	-1.07B	-7.0731

Io Biotech Inc Stock (IOBT) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2026-01-26	ダウングレード	Piper Sandler	Overweight → Neutral
2026-01-08	ダウングレード	Morgan Stanley	Equal-Weight → Underweight
2025-09-30	ダウングレード	Morgan Stanley	Overweight → Equal-Weight
2025-09-30	ダウングレード	TD Cowen	Buy → Hold

Io Biotech Inc (IOBT) 最新ニュース

Jun 08, 2026

IO Biotech (IOBT) common stock removed from Nasdaq in voluntary withdrawal - Stock Titan

Jun 08, 2026

Layoff Tracker: Fulcrum axes 85% of staff after walking away from lead asset - BioSpace

Jun 08, 2026

Jun 05, 2026

Fierce Biotech Layoff Tracker 2026: Fulcrum cuts 85% of staff; Novartis trims research team - Fierce Biotech

Jun 05, 2026

Jun 02, 2026

Major IO Biotech (IOBT) shareholder updates 27.4% stake as company enters Chapter 7 - Stock Titan

Jun 02, 2026

May 27, 2026

IOBTQ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

May 27, 2026

May 26, 2026

IO Biotech (IOBT) Holds Steady at $0.05 as Key Support and Resistance ConvergeTrend Continuation Trade - The Legal Advocate

May 26, 2026

May 25, 2026

IO Biotech Q3 2025 Earnings: EPS Beat of 60.67% Surprise, but No Revenue from Pre-Commercial PipelineEstimate Revision Count - The Legal Advocate

May 25, 2026

May 23, 2026

IO Biotech Inc. (IOBT) Hovers at $0.05 as Trading Activity Remains SubduedGamma Flip Level - The Legal Advocate

May 23, 2026

Io Biotech Inc (IOBT) 財務データ

収益

当期純利益

現金流量

EPS

ROIV

$30.04

1.04%

INCY

$108.53

0.65%

BNTX

$90.54

1.12%

RPRX

$54.87

0.76%

ONC

$264.48

1.62%

RVMD

$153.87

3.11%

Io Biotech Inc (IOBT)

Io Biotech Inc Stock (IOBT) Company Profile

Compare IOBT vs VRTX, REGN, ARGX, ALNY, RVMD

Io Biotech Inc Stock (IOBT) Upgrades & Downgrades

Io Biotech Inc (IOBT) 最新ニュース

IO Biotech (IOBT) common stock removed from Nasdaq in voluntary withdrawal - Stock Titan

Layoff Tracker: Fulcrum axes 85% of staff after walking away from lead asset - BioSpace

Fierce Biotech Layoff Tracker 2026: Fulcrum cuts 85% of staff; Novartis trims research team - Fierce Biotech

Major IO Biotech (IOBT) shareholder updates 27.4% stake as company enters Chapter 7 - Stock Titan

IOBTQ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

IO Biotech (IOBT) Holds Steady at $0.05 as Key Support and Resistance ConvergeTrend Continuation Trade - The Legal Advocate

IO Biotech Q3 2025 Earnings: EPS Beat of 60.67% Surprise, but No Revenue from Pre-Commercial PipelineEstimate Revision Count - The Legal Advocate

IO Biotech Inc. (IOBT) Hovers at $0.05 as Trading Activity Remains SubduedGamma Flip Level - The Legal Advocate

Io Biotech Inc (IOBT) 財務データ

収益

当期純利益

現金流量

EPS

IOBTに似た銘柄